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Preventative Medicine
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Abstract
An estimated 46 million adults in the U.S. are affected by arthritis,
with osteoarthritis (QA) being the most common. Due to the limlted
pharmacologic therapy available to treat this condition, many patients are turning to dietary supplements to relieve their symptoms.
Some of the most popular supplements available for the treatment
of QA are glucosamine, choneroitin and methylsulfonylmethane
'MSM}, but mamy less studied products are also available. Due to
limited eviderace of efficacy, It is difficult to make a strong recommendation for any of these pr©ductSi however, pharmacists must be
able to educate the patients that choose to use these supplements
in the treatment of their OA.

Introduction
Arthritis currently affects an estimated 46 million adults in the United
States alone, and rates are expected to rise dramatically to 67 million over the next 20 years. It is most common in adults 65 years and
older and consists of more than 100 different rheumatic diseases and
conditions that impact joints, joint tissue and other connective tissue. Osteoarthritis (OA) is the most common and is defined as the degeneration
of a joint's cartilage and underlying bone, leading to pain, inflammation
and stiffness in the joint. Due to the high prevalence, high lifetime risk of
developing OA and many other factors, this disease has become an important public health concern. It is currently the nation's leading cause of
disability, causing limited activity in approximately 19 million U.S. adults.
Due to the fact that it is so difficult for people to be physically active with
OA, it is a high risk factor for many other chronic diseases and conditions, including obesity, diabetes and cardiovascular disease. Arthritis
has been a large expense for the Uni~ed States over the past several
years, costing a total of $128 billion in 2003 alone. It is the reason for
approximately 992, 100 hospital visits and 44 million outpatient visits
every year. 1
In order to address this rising concern with arthritis, there are many
counseling points that pharmacists may give to their patients affected
by this disease. Advising patients to be physically active, maint~i~ a
healthy body weight, protect their joints, and schedule regular v1s1ts .
with a physician or even referring them to a self-management education
program can be extremely beneficial. 1 The mainstay over-the-counter
treatment option for relieving symptoms of OA is acetaminophen. Prescription treatment options are few, including COX-2 inhibitors, NSAIDs
and even prednisone; however, these drugs do not come without their
own adverse effects and risks. Often, patients with OA look to other
means of easing the pain and inflammation. Supplements are becoming
increasingly popular treatment options for those affected by the disease;
however, patients need to be cautious when purchasing these products.
Some of the most popular supplements available for the treatment of OA
include glucosamine, chondroitin and methylsulfonylmethane (MSM).

Glucosamine
Glucosamine is arguably the most popular supplement used for joint
health. There have been more than 20 studies performed to assess the
efficacy of glucosamine alone and in combination with other supplements to treat osteoarthritis of the knee.2-6 The outcomes of these trials
have been mixed; for every study performed that finds glucosamine effective, another study has been performed to find it ineffective. It is also
interesting to note that many trials backed by pharmaceutical companies
yielded clinically significant outcomes, whereas many independently
funded trials found no clinically significant outcomes. Despite many
mixed outcomes, there have been two large trials that suggest glucosamine could benefit some patient populations. The European GUIDE
trial compared the efficacy of glucosamine sulfate alone (1,500 mg once
daily) and acetaminophen (3,000 mg once daily) in treating osteoarthritis.7 The 318 enrolled patients were followed for six months, and results
proved glucosamine to be more effective than acetaminophen in treating
pain. The most recent American GAIT trial followed 1,500 patients for
six months and then 750 of those patients for an additional 18 months.
Patients were randomized to glucosamine HCL alone, chondroitin sulfate alone, glucosamine/chondroitin combination, celecoxib, or placebo. 8
The glucosamine/chondroitin combination was the only group besides
celecoxib to show significant reductions in pain, but this was only noted
in the group of patients who had the most severe pain index at study
onset. Interestingly, there was also a 55 percent placebo effect in this
group of patients. In both cases, adverse reactions were generally mild
GI effects like heartburn, diarrhea and nausea. The biggest controversy
with these two trials is the use of two different glucosamine salt forms HCL and sulfate. The GAIT trial found glucosamine HCL to be ineffective
alone, but the GUIDE trial did find the sulfate form to be effective alone.
The question also remains why glucosamine appears more effective in
combination than as a stand-alone therapy. The place of glucosamine in
current osteoarthritis patients has yet to be established, but recent studies have suggested it may have efficacy in some patient populations.
So, what do you tell a patient who is interested in using glucosamine?
First, explain that efficacy has only been established in certain patient
populations, and it may or may not be right for them. Next, you need to
inform your patient that the only form that has been proven efficacious is
the oral sulfate form. The sulfate form is typically more expensive (anywhere from $9 to $32 for a one-month supply) because it is more costly
to manufacture.9 Glucosamine is expensive regardless, but you want to
make sure your patient gets the most effective product for their money.
Do not recommend glucosamine cream because efficacy has not been
established. At least 1,500 mg daily is needed to be beneficial, and
this dose is often broken up into BID or TIO dosing. Research has also
proven that glucosamine must be used for a minimum of 30 to 90 days
to notice any effect. 10 Encourage the patient to try at least a 60-day trial
period before making the decision to continue or discontinue therapy.

Osteoarthritis: Natural Supplements for Joint Health
Chondroitin sulfate
Chondroitin, found naturally in the human body, is marketed as a
cartilage matrix enhancer that helps rebuild and prevent the breakdown
of cartilage, thereby maintaining healthy joint function.11 In the body, it
is a major component of connective tissue and joint cartilage, and its
ability to absorb water increases cartilage thickness and its capacity to
tolerate the impact of compressive forces. Additionally, it inhibits synovial enzymes, such as elastase and hyaluronidase, which are thought
to destroy cartilage and, thus, weaken joints. Synthesis of chondroitin
decreases with age. 12
Chondroitin is one of the most common over-the-counter supplements
that patients buy in an effort to improve their joint health, yet clinical
evidence supporting its effectiveness is limited and inconsistent. The
earliest trials that demonstrated its efficacy were not of high quality. 13
More recent and superior-quality studies show that chondroitin does not
reduce the pain associated with OA. While chondroitin most likely does
not have a place in OA therapy for symptom relief, current research
has examined its place in structural management of OA. Because of its
structure-modifying effect, chondroitin may slow OA progression. 14 A
meta-analysis examined this beneficial effect in patients with knee OA
and determined that it did have a significant protective effect on joint
narrowing space, but only after two years of daily treatment. Furthermore, this study also showed that chondroitin may slow the radiological
progression of OA with prolonged daily treatment. 15
A normal dose of chondroitin is 200-400 mg two to three times per day,
or 800-1,200 mg once daily, most often in combination with glucosamine
and other supplements. These combination products usually come as
a 60-day supply (120 count, taken twice daily), and prices range from
$19.99-$47.99, depending on the number of ingredients and the relative
milligram strength of each. There are also many dosage forms available,
including tablets, capsules, softgels, drinks and flavored powder packets
to add to water. 16
Due to insufficient quality clinical evidence supporting its effectiveness,
lack of symptom relief and high cost, chondroitin should not be recommended to patients. Further studies need to be performed to determine if
the structure-modifying effect does slow the progression of OA and if this
can be associated with any clinically significant outcomes for patients,
such as improved quality of life.

MSM
MSM is an organic compound found in green plants, certain species of
algae, fruits, vegetables, grains, bovines and humans. It is the oxidized
metabolite of dimethylsulfoxide (DMSO) and is commercially produced
by combining DMSO with hydrogen peroxide. Preliminary research
suggests it might inhibit the degenerative changes in joints, thus helping
with pain and swelling and possibly improving joint or physical function. 17
This might be due to the compound's ability to increase blood flow,
reduce muscle spasms and inhibit type C nerve fibers from transmitting
pain impulses and its power to limit the release of inflammatory mediators. The sulfur present in MSM also is an important element in proteins,
connective tissues, hormones and enzymes and, therefore, is significant
in the formation of cartilage.18 MSM has been shown to be safe when
taken orally in amounts up to 6 g per day for three months, but safety
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when used topically or in pregnancy has not yet been established.
Adverse effects include nausea, diarrhea, bloating, headache, fatigue,
insomnia and difficulty concentrating; however, these effects have not
been very prevalent. Additional side effects in some patients include pruritus and enhanced allergy symptoms. In the treatment of osteoarthritis,
MSM should be taken as 500 mg three times daily up to 3 g twice daily.17
A 30-day supply of 1,500 mg MSM tablets can cost anywhere from $10
to $20. 19
A randomized, double-blind, placebo-controlled pilot clinical trial was
conducted to evaluate the efficacy of MSM in the treatment of osteoarthritis pain in the knee. Fifty patients were given either placebo (n=25) or
3 g of MSM twice daily (n=25) and were evaluated for 12 weeks. Primary
outcome parameters were evaluated using the Western Ontario and McMaster University Osteoarthritis Index VAS (WOMAC), which included
pain, stiffness, physical function and aggregated total symptoms. Secondary parameters included patient and physician global assessments
(disease status and response to therapy) and overall health-related
quality of life. Of the 40 patients who completed the study, the MSM
group was found to have a significant reduction in WOMAC pain and
impairment of physical function (p<0.05). MSM also was found to significantly improve the performance of activities of daily living compared
to placebo (p<0.05). There was not a significant change in stiffness or
aggregated total symptoms. Even though there was a statistically significant improvement in pain and physical function, the small difference
in comparison to the placebo group indicates little clinical significance.
Researchers also state that, although few adverse events were noted,
the long-term benefits and safety cannot be determined from this trial
and more studies need to be conducted.20
On the other hand, another randomized, double-blind, parallel, controlled
clinical trial that assessed the efficacy of glucosamine, MSM, and their
combination in osteoarthritis did find significantly positive clinical findings. A total of 118 patients received either 500 mg glucosamine, 500
mg MSM, glucosamine and MSM, or placebo three times daily for 12
weeks. Pain, swelling, the Lequesne index (assessed pain or discomfort, maximum distance walked and activities of daily living) and use of
rescue medication were all evaluated as outcome parameters. After 12
weeks of therapy, MSM alone was found to significantly decrease the
pain and swelling index from 1.53 ± 0.51 to 0.74 ± 0.65 (p<0.001) with
the combination product producing even greater effects. The glucosamine/MSM combination also demonstrated a significant reduction in
the Lequesne index (p<0.001 ). Overall, MSM alone and in combination
with glucosamine were found to demonstrate significant analgesic and
anti-inflammatory actions in the treatment of osteoarthritis. 21
Due to the conflicting evidence regarding efficacy and the unknown
safety of MSM, more studies need to be conducted. Any patients taking this supplement in the long-term treatment of osteoarthritis should
consult a physician before beginning use.

Other Products
There are numerous other products and therapies thought to have a
benefit in OA. The table below discusses some of the more popular
ones, including their possible benefit and presumed effectiveness, based
on limited clinical evidence: 13
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Product
SAMe

Avocado/soybean

Possible Benefit
Effectiveness
Likely effective
Comparable to celecoxib/
other NSAIDS for decreasing
OA symptoms with fewer side
effects. May require longer
treatment period.
Improves pain, overall disability Possibly effective

Possibly effective
Slows progression, not
development of disease
Symptom relief through
Effective
Camphor (topical}
counterirritant effects
Possibly effective
Niacin (Vitamin B3) Improves joint flexibility and
reduces inflammation
Reduces risk of cartilage loss Possibly effective
Vitamin C
and disease progression
Probably ineffective
Vitamin E
No decrease in symptoms,
slows cartilage loss, reduces
risk of disease development
Insufficient evidence: DMSO, gelatin, ginger, vitamin B5, selenium
Nonpharmacologic treatment: acupuncture, mineral baths, magnet therapy, yoga
Beta-carotene

OTC Regulation
The lax regulations surrounding dietary supplements are an important
counseling point for all patients. The Dietary Supplement Health and
Education Act (OSHEA) of 1994 mandated that the dietary supplement
manufacturer is responsible for product safety, not the Food and Drug Administration (FDA). 22 Manufacturers do not need to register their products
with the FDA before marketing, and the FDA can only withdraw a product
from the market after multiple serious adverse drug reactions (ADRs) have
occurred. Some companies choose to undergo investigation and certification through paid outside sources, but this is not mandatory. 23 The FDA
can post lists of dietary supplements that may contain harmful ingredients
but can only pull these products off the market after there have been
multiple documented cases of serious ADRs (usually death). 24 Encourage
patients to research the product manufacturer before buying their dietary
supplements.

Conclusion
Osteoarthritis affects 46 million Americans and is the leading cause of disability .1 As America ages, many are looking for ways to prevent problems or
treat existing problems without prescription medication. Glucosamine is likely
to be efficacious, but patients must be careful of which type they buy. MSM
and chondroitin lack strong evidence for use at present, and MSM has yet to
prove satety, so patients should talk to their doctor prior to starting therapy.
At this time, there is a definite lack of evidence proving success or failure for
many natural products on the market; however, as health care professionals,
it is our responsibility to educate our patients when more evidence has been
brought to light about the herbal products they may be taking.
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